Willow Biosciences Inc
OTC:CANSF
Willow Biosciences Inc
Willow Biosciences, Inc. is a biotechnology company. The company is headquartered in Calgary, Alberta and currently employs 49 full-time employees. The company went IPO on 2017-09-14. The firm's products include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabidivarin (CBDV), cannabigerovarin (CBGV), tetrahydrocannabivarin (THCV) and cannabinol (CBN). The firm has two laboratories for research and development in Mountain View, California and Burnaby, British Columbia. In addition, the Company has an analytical testing lab in Burnaby where it provides third-party analytical testing and product development services to the cannabis industry through its subsidiary Willow Analytics Inc. The company also offers testing for all forms of cannabis products, including flower, concentrates and extracted ingredients.
Willow Biosciences, Inc. is a biotechnology company. The company is headquartered in Calgary, Alberta and currently employs 49 full-time employees. The company went IPO on 2017-09-14. The firm's products include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabidivarin (CBDV), cannabigerovarin (CBGV), tetrahydrocannabivarin (THCV) and cannabinol (CBN). The firm has two laboratories for research and development in Mountain View, California and Burnaby, British Columbia. In addition, the Company has an analytical testing lab in Burnaby where it provides third-party analytical testing and product development services to the cannabis industry through its subsidiary Willow Analytics Inc. The company also offers testing for all forms of cannabis products, including flower, concentrates and extracted ingredients.
